Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBegenik, Hüseyin
dc.contributor.authorTurkdogan, Mehmed Kursad
dc.contributor.authorDülger, Ahmet Cumhur
dc.contributor.authorAldemir, Mehmet Naci
dc.contributor.authorEsen, Ramazan
dc.contributor.authorMete, Rafet
dc.date.accessioned2022-05-11T14:39:51Z
dc.date.available2022-05-11T14:39:51Z
dc.date.issued2013
dc.identifier.issn1426-3912
dc.identifier.issn1644-4124
dc.identifier.urihttps://doi.org/10.5114/ceji.2013.37741
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8765
dc.description.abstractAim: To evaluate parameters of cellular and humoral immunity in gastric and esophageal cancer patients. Material and methods: In this study, we recruited 40 patients with newly diagnosed esophageal cancer (20 of them) or stomach cancer (20 of them) and 20 healthy individuals of similar age as a control group. In the study and control groups we measured CD3, CD4, CD8, CD19, CD4/CD8 ratio and the ratio of natural killer cells using the flow cytometer device. Results were evaluated with factorial analysis of variance and Duncan test. Results: The CD3 and CD8 ratios were significantly higher in patients with esophageal cancer (p = 0.012, p = 0.003, respectively) and the ratio of NK cells was significantly higher in patients with stomach cancer (p = 0.001) when compared to the control group. The ratio of CD19 was significantly lower in the two cancer groups (p = 0.031). There were no significant differences in the ratio of CD4 and CD4/CD8 between the groups. No correlation between the stage of cancer and the ratio of CD cells was detected. Discussion: In conclusion, understanding of the cancer immunology of esophageal and stomach cancer will provide insight into the pathogenesis of the cancer Therefore, further and extensive cancer immunology studies should be conducted to understand the nature of the upper gastrointestinal tract cancers.en_US
dc.language.isoengen_US
dc.publisherTermedia Publishing House Ltden_US
dc.identifier.doi10.5114/ceji.2013.37741
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectesophageal canceren_US
dc.subjectgastric canceren_US
dc.subjectcellular and humoral immunityen_US
dc.subjectRegulatory T-Cellsen_US
dc.subjectLymphocyte Subsetsen_US
dc.subjectKiller-Cellsen_US
dc.subjectCarcinomaen_US
dc.subjectImmunotherapyen_US
dc.subjectTobaccoen_US
dc.subjectStageen_US
dc.titlePeripheral blood levels of cellular and humoral immunity parameters in esophageal and gastric cancer patientsen_US
dc.typearticleen_US
dc.relation.ispartofCentral European Journal of Immunologyen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-5594-782X
dc.identifier.volume38en_US
dc.identifier.issue3en_US
dc.identifier.startpage355en_US
dc.identifier.endpage357en_US
dc.institutionauthorMete, Rafet
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid10242147700
dc.authorscopusid6603445211
dc.authorscopusid36476941100
dc.authorscopusid56644431400
dc.authorscopusid6507569757
dc.authorscopusid36608599700
dc.authorwosidTÜRKDOĞAN, MEHMED KÜRŞAD/ABG-4331-2020
dc.identifier.wosWOS:000327830900012en_US
dc.identifier.scopus2-s2.0-84889584922en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster